247 filings
Page 2 of 13
8-K
r2pjpb avijcy7gp
25 May 23
Other Events
4:31pm
8-K
oxjfuax620 wuv
9 May 23
Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results
4:57pm
8-K
vn7dfxa23v6s u0cdctd
31 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
s4jglhac
15 Mar 23
Vaxart Provides Business Update and Full Year 2022 Financial Results
7:58pm
8-K
3w0f4iff4dgcn 9j
19 Dec 22
Vaxart Names Phillip Lee as Chief Financial Officer
5:25pm
8-K
7tlu5 zkvr3d
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm
8-K
yfhek
8 Nov 22
Vaxart Provides Business Update and Reports Third Quarter 2022 Financial Results
4:10pm
8-K
cmth2vp su
1 Sep 22
Regulation FD Disclosure
7:05am
8-K
l7j9t50733v0rpsxxc8
25 Aug 22
Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
4:09pm
8-K
79sw3wt68e24 fph7
8 Aug 22
Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results
4:06pm
8-K/A
zynuz2ql
5 Aug 22
Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4
8:02am
8-K
ie8s5
28 Jul 22
Other Events
8:00am
8-K
xicmx
8 Jul 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
lbp 4p2jo85ec
6 Jul 22
Entry into a Material Definitive Agreement
4:02pm
8-K
dgz7ds
28 Jun 22
Other Events
5:09pm
8-K
6a09x0e
16 Jun 22
Management to discuss progress on its programs, annual stockholders’ meeting proposals
4:06pm
8-K
mtxetb
8 Jun 22
Vaxart Announces Adjournment of Annual Meeting of Stockholders
4:06pm
8-K
zma3 h6e5
6 Jun 22
Other Events
4:03pm
8-K
zgec6 nr51ou5
11 May 22
Departure of Directors or Certain Officers
5:27pm
8-K
f7twsn1b0slvbeh paco
9 May 22
Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results
5:51pm